kit11848 (Sino Biological)
Structured Review
Kit11848, supplied by Sino Biological, used in various techniques. Bioz Stars score: 94/100, based on 9 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/kit11848/Human+IL2+ELISA+Kit/pmc12303003-52-8-4
Average 94 stars, based on 9 article reviews
Images
Related Articles
Incubation:Article Title: Antitumor activity of Z15-0-2, a bispecific nanobody targeting PD-1 and CTLA-4. Article Snippet: .. After incubation, the culture supernatants were collected and assessed for the secretion of IL-2 using the Enzyme-linked Immunosorbent Assay:Article Title: Antitumor activity of Z15-0-2, a bispecific nanobody targeting PD-1 and CTLA-4. Article Snippet: .. After incubation, the culture supernatants were collected and assessed for the secretion of IL-2 using the Article Title: Rational design, optimization, and biological evaluation of novel pyrrolo-pyridone derivatives as potent and orally active Cbl-b inhibitors. Article Snippet: Casitas B-lineage lymphoma proto-oncogene-b (Cbl-b), a member of the Cbl family of RING finger E3 ubiquitin ligases, plays a critical role in negatively regulating T-cell, natural killer (NK) cell, and B-cell activation.. Inhibiting Cbl-b has emerged as a promising immuno-oncology strategy to enhance immune cell function.. Here, we describe the rational design and optimization of pyrrolo-pyridone derivatives as potent Cbl-b inhibitors. Cell Culture:Article Title: Rational design, optimization, and biological evaluation of novel pyrrolo-pyridone derivatives as potent and orally active Cbl-b inhibitors. Article Snippet: Casitas B-lineage lymphoma proto-oncogene-b (Cbl-b), a member of the Cbl family of RING finger E3 ubiquitin ligases, plays a critical role in negatively regulating T-cell, natural killer (NK) cell, and B-cell activation.. Inhibiting Cbl-b has emerged as a promising immuno-oncology strategy to enhance immune cell function.. Here, we describe the rational design and optimization of pyrrolo-pyridone derivatives as potent Cbl-b inhibitors. other:Article Title: Interferon-α and thymosin-α1 plus tislelizumab enhance CD8 + T cell cytotoxicity toward pancreatic ductal adenocarcinoma Article Snippet: |
